Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients

OBJECTIVES: To evaluate the safety of antimotility agents (AAs) in a population of patients with hematologic malignancies and concurrent Clostridioides difficile infection (CDI) and to describe the outcomes of AA use in a hospital setting. PATIENTS AND METHODS: We used the electronic health record t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuon, Carla, Wannier, Rae, Sterken, David, Fang, Margaret C., Wolf, Jeffrey, Prasad, Priya A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749233/
https://www.ncbi.nlm.nih.gov/pubmed/33367215
http://dx.doi.org/10.1016/j.mayocpiqo.2020.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749233/
https://www.ncbi.nlm.nih.gov/pubmed/33367215
http://dx.doi.org/10.1016/j.mayocpiqo.2020.06.005

Ejemplares similares